Explore

Companies

Drugs

/

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Fed

11

Pipeline Programs↗

3

Active Trials↗

35

Companies Involved↗

Fed is an emerging landscape with 11 programs across 35 companies.

Intelligence

Pipeline Metrics

Competitive Density

39/100

Pipeline Velocity

0/100

Mech. Concentration

33/100

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

Preclinical11

Fosinopril

Bristol-Myers Squibb

Zaleplon

Pfizer

Terbinafine

Novartis

Perindopril Erbumine

Symplmed Pharmaceuticals LLC

Naratriptan Hydrochoride

Roxane Laboratories

Phase 1

No programs

Phase 2

No programs

Phase 3

No programs

Approved

No programs

Analysis

Trial Status

231

clinical trials

Completed216 · 94%

Unknown status10 · 4%

Not yet recruiting2 · 1%

Withdrawn1 · 0%

Available1 · 0%

Recruiting1 · 0%

Clinical Trials

Trial Activity

231 trials

Phenylalanine, Methionine and Histidine Requirements in TPN Fed Neonates

Recruiting·TThe Hospital for Sick Children·N/A·NCT05562310·60 enrolled

Bioequivalence Study of Pentoxifylline 400 Mg in Healthy Subjects Under Fasting and Fed Conditions

Not yet recruiting·CCentro de Atencion e Investigacion Medica·Phase 4·NCT06823362·40 enrolled

Isoleucine, Leucine, Valine and Tryptophan Requirements in TPN Fed Neonates

Not yet recruiting·TThe Hospital for Sick Children·N/A·NCT06372314·80 enrolled

OTR Tablet 40 mg Fed-state Bioequivalence Study

Completed·MMundipharma (China) Pharmaceutical Co. Ltd·Phase 1·NCT03398330·42 enrolled

Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions

Completed·OOverseas Pharmaceuticals, Ltd.·Phase 1·NCT06589921·24 enrolled

Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male.

Completed· Boehringer Ingelheim logo

Boehringer Ingelheim·Phase 1·NCT02417844·34 enrolled

Topiramate 25 mg Capsules Under Fed Conditions

Completed· Teva logo

Teva·Phase 1·NCT00904943·18 enrolled

Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fed Conditions

Completed· Novartis logo

Novartis·Phase 1·NCT00857142·32 enrolled

A Bioequivalence Study of Isosorbide-5-Mononitrate Extended-Release Tablets Under Fed Conditions in Healthy Subjects

Completed· Qilu Pharmaceutical Co., Ltd. logo

Qilu Pharmaceutical Co., Ltd.·Phase 1·NCT03557580·12 enrolled

Bioequivalency Study of Torsemide Tablets Under Fed Conditions

Completed·RRoxane Laboratories·N/A·NCT00602615·28 enrolled

Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fed Conditions

Completed·—·Phase 1·NCT01286701·18 enrolled

Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fed Study

Completed·RRanbaxy Laboratories Limited·N/A·NCT01654718·40 enrolled

Paxil CR Bioequivalence Study Brazil - Fed Administration

Completed· GSK logo

GSK·Phase 1·NCT01339247·60 enrolled

Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fed Condition

Completed·IIPCA Laboratories Ltd.·Phase 1·NCT01831687·36 enrolled

Fed Bioequivalence Study of CBZ Formulations

Completed·CCenter for Clinical Pharmacology Research Bdbeq S.A.·Phase 1·NCT02132897·20 enrolled

Page 1 of 16

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)